22-May-2012 - ‘CROs: look at the entire portfolio, not just the individual project, when planning clinical studies,’ says DIA’s adaptive design scientific working group.
21-May-2012 - Evotec and 4-Antibody have teamed up to offer a new antibody testing service.
16-May-2012 - SNBL USA has invested in ‘social housing’ at its lab in Everett, Washington citing ‘recent reductions’ in US non-human primate lab capacity as the driver.
15-May-2012 - Preclinical services firm SNBL has fixed most of the deficiencies observed during a US FDA inspection in 2010 and says it is working to ‘quickly’ resolve the remaining issues.
15-May-2012 - BASi is planning further cost cutting actions after continued weakness in toxicology led to a double-digit drop in revenue.
14-May-2012 - WuXi PharmaTech beat expectations in the first quarter as strong demand for manufacturing and laboratory services continued.
10-May-2012 - MPI Research must reconfigure its enclosures after they led to the death of a non-human primate, a USDA report obtained by animal rights activists shows.
07-May-2012 - The CEO of Charles River said asset transfer strategic deals make little “rational sense” to clients or CROs.
30-Apr-2012 - Outsourcing-Pharma looks at the wages of the remaining big four public CROs and how they compare to operating income.
26-Apr-2012 - Pressures on Indian CROs hit first quarter instrument and research materials sales at Waters and Sigma-Aldrich.
23-Apr-2012 - Analysts expect Covance to cut toxicology capacity in response to continued weak demand for GLP services.
19-Apr-2012 - Half of large pharma firms plan to offshore more discovery and early-stage work in the next two to five years, a survey found.
18-Apr-2012 - Australian preclinical CRO vivoPharm has bought toxicology testing firm RMIT Drug Discovery Technologies (RDDT) and will relocated to a new Melbourne HQ.
17-Apr-2012 - Positive survey results have added to evidence that outsourcing of drug discovery can partly offset weakness in GLP toxicology.
05-Apr-2012 - Outsourcing-Pharma presents a roundup of recent CRO deals, including agreements at Quintiles, MPI, and AMRI.
04-Apr-2012 - Catalent wants to build on its European expansions by replicating the end-to-end drug development services model in emerging markets.
03-Apr-2012 - Sigma-Aldrich plans to grow its new biologics toxicology services unit by creating targeted cell lines and animal models.
02-Apr-2012 - Affymetrix will distribute a mircoarray developed by Almac for personalised medicine development applications under an exclusive global distribution deal.
22-Mar-2012 - AMRI is to end operations at its discovery and chemistry services facility in Hungary by the end of next week.
20-Mar-2012 - The virtual development model needs a string of successes or blockbusters to convince the ‘herd’ of its merits, an expert said.
15-Mar-2012 - Two major ferry companies have decided to stop shipping animals used in preclinical drug development to the UK, prompting concerns about the future of the country’s research sector.
15-Mar-2012 - Growth in demand for toxicology services will be weak for the foreseeable future as the sector has “structurally changed”, analysts said after SOT.
14-Mar-2012 - UK drug major AstraZeneca has contracted BioFocus and Argenta to provide it with discovery services just weeks cutting its internal R&D capacity.
13-Mar-2012 - Preclinical CRO CiToxLAB has added inhalation testing capacity, citing growing demand from Pharmas and chemicals firms as key driver for the investment.
13-Mar-2012 - WuXi expects its GLP toxicology unit to turn profitable this year and it, like ShangPharma, is pinning its growth hopes on new services.